+
Open data
-
Basic information
| Entry | Database: PDB / ID: 9n4k | ||||||
|---|---|---|---|---|---|---|---|
| Title | CryoEM structure of ALK2-ActRIIB bound to BMP6 | ||||||
Components |
| ||||||
Keywords | SIGNALING PROTEIN / TGFB / Signaling / Receptor / Bone Morphogenetic Protein / ALK2 / Ligand / Growth Factor | ||||||
| Function / homology | Function and homology informationpositive regulation of aldosterone biosynthetic process / positive regulation of aldosterone secretion / Regulation of signaling by NODAL / enzyme activator complex / activin receptor activity / activin receptor activity, type II / lymphatic endothelial cell differentiation / positive regulation of activin receptor signaling pathway / negative regulation of adherens junction organization / endocardial cushion cell fate commitment ...positive regulation of aldosterone biosynthetic process / positive regulation of aldosterone secretion / Regulation of signaling by NODAL / enzyme activator complex / activin receptor activity / activin receptor activity, type II / lymphatic endothelial cell differentiation / positive regulation of activin receptor signaling pathway / negative regulation of adherens junction organization / endocardial cushion cell fate commitment / venous blood vessel development / lymphangiogenesis / mitral valve morphogenesis / trophoblast cell migration / BMP receptor complex / positive regulation of chondrocyte differentiation / BMP receptor activity / endocardial cushion fusion / cardiac muscle cell fate commitment / atrial septum primum morphogenesis / retina vasculature development in camera-type eye / positive regulation of cardiac epithelial to mesenchymal transition / positive regulation of endothelial cell differentiation / acute inflammatory response / type B pancreatic cell development / positive regulation of determination of dorsal identity / transforming growth factor beta receptor activity, type I / embryonic foregut morphogenesis / smooth muscle cell differentiation / activin receptor activity, type I / activin receptor complex / artery development / BMP receptor binding / endochondral ossification / endocardial cushion formation / pharyngeal system development / receptor protein serine/threonine kinase / eye development / transmembrane receptor protein serine/threonine kinase activity / activin binding / cellular response to BMP stimulus / Signaling by BMP / male genitalia development / pattern specification process / negative regulation of cell-cell adhesion mediated by cadherin / Signaling by Activin / negative regulation of activin receptor signaling pathway / positive regulation of vascular permeability / activin receptor signaling pathway / embryonic heart tube morphogenesis / Signaling by NODAL / gastrulation with mouth forming second / dorsal/ventral pattern formation / positive regulation of lipopolysaccharide-mediated signaling pathway / pancreas development / transforming growth factor beta binding / cartilage development / determination of left/right symmetry / negative regulation of ossification / kinase activator activity / atrioventricular valve morphogenesis / anterior/posterior pattern specification / negative regulation of cold-induced thermogenesis / cell surface receptor protein serine/threonine kinase signaling pathway / skeletal system morphogenesis / insulin secretion / organ growth / neural crest cell migration / growth factor binding / branching involved in blood vessel morphogenesis / negative regulation of G1/S transition of mitotic cell cycle / ventricular septum morphogenesis / SMAD binding / odontogenesis of dentin-containing tooth / mesoderm development / germ cell development / roof of mouth development / peptide hormone binding / mesoderm formation / positive regulation of intracellular signal transduction / positive regulation of SMAD protein signal transduction / response to magnesium ion / regulation of ossification / response to retinoic acid / positive regulation of osteoblast differentiation / positive regulation of bone mineralization / BMP signaling pathway / blood vessel remodeling / negative regulation of signal transduction / response to glucose / positive regulation of endothelial cell proliferation / positive regulation of neuron differentiation / protein serine/threonine/tyrosine kinase activity / transforming growth factor beta receptor signaling pathway / lung development / response to glucocorticoid / protein tyrosine kinase binding / cytokine activity / positive regulation of epithelial cell proliferation / response to activity Similarity search - Function | ||||||
| Biological species | Homo sapiens (human) | ||||||
| Method | ELECTRON MICROSCOPY / single particle reconstruction / cryo EM / Resolution: 3.2 Å | ||||||
Authors | Goebel, E.J. / Saotome, K. / Franklin, M.C. | ||||||
| Funding support | United States, 1items
| ||||||
Citation | Journal: Proc Natl Acad Sci U S A / Year: 2025Title: CryoEM structure of ALK2:BMP6 reveals distinct mechanism that allow ALK2 to interact with both BMP and activin ligands. Authors: Erich J Goebel / Senem Aykul / Warren W Hom / Kei Saotome / Aris N Economides / Matthew C Franklin / Vincent J Idone / ![]() Abstract: Ligands in the transforming growth factor β (TGF-β) family [activins, Bone Morphogenetic Proteins (BMPs), and TGF-βs] signal by bringing together two type I and two type II receptors. Activin ...Ligands in the transforming growth factor β (TGF-β) family [activins, Bone Morphogenetic Proteins (BMPs), and TGF-βs] signal by bringing together two type I and two type II receptors. Activin receptor-like kinase-2 (ALK2) is the only type I receptor among the seven TGF-β type I receptors that interacts with both activin and BMP ligands. With BMPs, ALK2 acts as a signaling receptor to activate small mothers against decapentaplegic 1 (SMAD1)/5/8 signaling. Alternatively, with activins, such as Activin A (ActA), ALK2 forms nonsignaling complexes that negatively regulate ALK2 and ActA signaling. To gain insight into how ALK2 interacts with two distinct classes of ligands, we resolved the cryoelectron microscopy structure of ALK2 in complex with the type II receptor, ActRIIB, and the ligand, BMP6, in parallel with the corresponding structure with ALK3 for direct comparison. These structures demonstrate that ALK2 and ALK3 utilize different mechanisms to interact with BMP6 at the wrist interface, with ALK2 relying on BMP6 glycosylation and ALK3 relying on a salt bridge. Modeling of ALK2:ActA reveals that binding relies on ActA's fingertip region, mirroring the interaction of ActA with its other receptor, ALK4. Our results demonstrate that ALK2 is a "hybrid" receptor that incorporates features of BMP type I receptors such as ALK3 at the wrist interface and an activin type I receptor such as ALK4 at the fingertip. | ||||||
| History |
|
-
Structure visualization
| Structure viewer | Molecule: Molmil Jmol/JSmol |
|---|
-
Downloads & links
-
Download
| PDBx/mmCIF format | 9n4k.cif.gz | 130.1 KB | Display | PDBx/mmCIF format |
|---|---|---|---|---|
| PDB format | pdb9n4k.ent.gz | 98.3 KB | Display | PDB format |
| PDBx/mmJSON format | 9n4k.json.gz | Tree view | PDBx/mmJSON format | |
| Others | Other downloads |
-Validation report
| Arichive directory | https://data.pdbj.org/pub/pdb/validation_reports/n4/9n4k ftp://data.pdbj.org/pub/pdb/validation_reports/n4/9n4k | HTTPS FTP |
|---|
-Related structure data
| Related structure data | ![]() 48883MC ![]() 9mirC M: map data used to model this data C: citing same article ( |
|---|---|
| Similar structure data | Similarity search - Function & homology F&H Search |
-
Links
-
Assembly
| Deposited unit | ![]()
|
|---|---|
| 1 |
|
-
Components
-Activin receptor type- ... , 2 types, 4 molecules AFCD
| #1: Protein | Mass: 14933.380 Da / Num. of mol.: 2 Source method: isolated from a genetically manipulated source Source: (gene. exp.) Homo sapiens (human) / Gene: ACVR2B / Production host: ![]() References: UniProt: Q13705, receptor protein serine/threonine kinase #3: Protein | Mass: 13189.880 Da / Num. of mol.: 2 Source method: isolated from a genetically manipulated source Source: (gene. exp.) Homo sapiens (human) / Gene: ACVR1, ACVRLK2 / Production host: ![]() References: UniProt: Q04771, receptor protein serine/threonine kinase |
|---|
-Protein , 1 types, 2 molecules BE
| #2: Protein | Mass: 15695.711 Da / Num. of mol.: 2 Source method: isolated from a genetically manipulated source Source: (gene. exp.) Homo sapiens (human) / Gene: BMP6, VGR / Production host: ![]() |
|---|
-Sugars , 3 types, 10 molecules 


| #4: Polysaccharide | | #5: Sugar | ChemComp-NAG / #6: Sugar | |
|---|
-Details
| Has ligand of interest | N |
|---|---|
| Has protein modification | Y |
-Experimental details
-Experiment
| Experiment | Method: ELECTRON MICROSCOPY |
|---|---|
| EM experiment | Aggregation state: PARTICLE / 3D reconstruction method: single particle reconstruction |
-
Sample preparation
| Component | Name: Ternary complex of ALK2-ActRIIB with BMP6 / Type: COMPLEX / Details: ALK2-ActRIIB fused by Antibody Hinge region / Entity ID: #1-#3 / Source: RECOMBINANT | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Molecular weight | Value: 0.08 MDa / Experimental value: NO | |||||||||||||||
| Source (natural) | Organism: Homo sapiens (human) | |||||||||||||||
| Source (recombinant) | Organism: ![]() | |||||||||||||||
| Buffer solution | pH: 7.5 / Details: 50mM Tris-HCL, 100mM NaCl | |||||||||||||||
| Buffer component |
| |||||||||||||||
| Specimen | Conc.: 3 mg/ml / Embedding applied: NO / Shadowing applied: NO / Staining applied: NO / Vitrification applied: YES Details: Sample was mono disperse following purification over size exclusion chromatography. | |||||||||||||||
| Specimen support | Grid material: GOLD | |||||||||||||||
| Vitrification | Cryogen name: ETHANE |
-
Electron microscopy imaging
| Experimental equipment | ![]() Model: Titan Krios / Image courtesy: FEI Company |
|---|---|
| Microscopy | Model: TFS KRIOS |
| Electron gun | Electron source: FIELD EMISSION GUN / Accelerating voltage: 300 kV / Illumination mode: OTHER |
| Electron lens | Mode: BRIGHT FIELD / Nominal magnification: 105000 X / Nominal defocus max: 2400 nm / Nominal defocus min: 800 nm / Alignment procedure: BASIC |
| Specimen holder | Cryogen: NITROGEN / Specimen holder model: FEI TITAN KRIOS AUTOGRID HOLDER |
| Image recording | Electron dose: 40 e/Å2 / Film or detector model: GATAN K3 BIOQUANTUM (6k x 4k) |
-
Processing
| EM software | Name: PHENIX / Version: 1.21.2_5419 / Category: model refinement | ||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CTF correction | Type: PHASE FLIPPING AND AMPLITUDE CORRECTION | ||||||||||||||||||||||||
| Symmetry | Point symmetry: C2 (2 fold cyclic) | ||||||||||||||||||||||||
| 3D reconstruction | Resolution: 3.2 Å / Resolution method: FSC 0.143 CUT-OFF / Num. of particles: 42185 / Symmetry type: POINT | ||||||||||||||||||||||||
| Atomic model building | Protocol: RIGID BODY FIT / Space: REAL Details: Initial fitting was performed in ChimeraX and real-space refinement was carried out within Phenix. | ||||||||||||||||||||||||
| Atomic model building | 3D fitting-ID: 1 / Source name: PDB / Type: experimental model
|
Movie
Controller
About Yorodumi




Homo sapiens (human)
United States, 1items
Citation


PDBj




surface plasmon resonance




